Exact Mass: 451.1236
Exact Mass Matches: 451.1236
Found 330 metabolites which its exact mass value is equals to given mass value 451.1236
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flucythrinate
(1R)-Hydroxy-(2R)-glutathionyl-1,2-dihydronaphthalene
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
(1R)-Glutathionyl-(2R)-hydroxy-1,2-dihydronaphthalene
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
(1S)-Hydroxy-(2S)-glutathionyl-1,2-dihydronaphthalene
This compound belongs to the family of Peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.
4-Phenylbutyl glucosinolate
4-Phenylbutyl glucosinolate is found in brassicas. 4-Phenylbutyl glucosinolate is present in horseradish (Armoracia lapathifolia). Present in horseradish (Armoracia lapathifolia). 4-Phenylbutyl glucosinolate is found in horseradish and brassicas.
5-O-Feruloylnigrumin
5-O-Feruloylnigrumin is found in fruits. 5-O-Feruloylnigrumin is a constituent of the seeds of Ribes nigrum (blackcurrant). Constituent of the seeds of Ribes nigrum (blackcurrant). 5-O-Feruloylnigrumin is found in fruits.
4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide
5-Chloro-N-(4-methoxy-3-(piperazin-1-yl)phenyl)-3-methylbenzo[b]thiophene-2-sulfonamide
Betrixaban
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins
4H-Pyrido(4',3':4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 7,8,9,10-tetrahydro-6-(2-chlorophenyl)-9-(cyclopropylcarbonyl)-1,4-dimethyl-, (S)-
Rigosertib
Succinyl-trialanine-4-nitroanilide
D-Phenylalanine, 4-fluoro-N-(((5-(4-fluorophenyl)-2-benzofuranyl)methoxy)carbonyl)-
(4E)-5-{6-O-[(2E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]-beta-glucopyranosylsulfanyl}pent-4-enenitrile
(1S,4R)-1-(beta-D-Glucopyranosyloxy)-4-(6-deoxy-beta-D-gulopyranosyloxy)-2-cyclopentene-1-carboxamide
Ala Cys Cys Arg
Ala Cys Met Gln
Ala Cys Gln Met
Ala Cys Arg Cys
Ala Met Cys Gln
Ala Met Gln Cys
Ala Gln Cys Met
Ala Gln Met Cys
Ala Arg Cys Cys
Cys Ala Cys Arg
Cys Ala Met Gln
Cys Ala Gln Met
Cys Ala Arg Cys
Cys Cys Ala Arg
Cys Cys Ile Asn
Cys Cys Leu Asn
Cys Cys Asn Ile
Cys Cys Asn Leu
Cys Cys Gln Val
Cys Cys Arg Ala
Cys Cys Val Gln
Cys Asp Asn Thr
Cys Asp Gln Ser
Cys Asp Ser Gln
Cys Asp Thr Asn
Cys Glu Asn Ser
Cys Glu Ser Asn
Cys Gly Ser Trp
Cys Gly Trp Ser
Cys Ile Cys Asn
Cys Ile Asn Cys
Cys Leu Cys Asn
Cys Leu Asn Cys
Cys Met Ala Gln
Cys Met Gln Ala
Cys Asn Cys Ile
Cys Asn Cys Leu
Cys Asn Asp Thr
Cys Asn Glu Ser
Cys Asn Ile Cys
Cys Asn Leu Cys
Cys Asn Ser Glu
Cys Asn Thr Asp
Cys Gln Ala Met
Cys Gln Cys Val
Cys Gln Asp Ser
Cys Gln Met Ala
Cys Gln Ser Asp
Cys Gln Val Cys
Cys Arg Ala Cys
Cys Arg Cys Ala
Cys Ser Asp Gln
Cys Ser Glu Asn
Cys Ser Gly Trp
Cys Ser Asn Glu
Cys Ser Gln Asp
Cys Ser Trp Gly
Cys Thr Asp Asn
Cys Thr Asn Asp
Cys Val Cys Gln
Cys Val Gln Cys
Cys Trp Gly Ser
Cys Trp Ser Gly
Asp Cys Asn Thr
Asp Cys Gln Ser
Asp Cys Ser Gln
Asp Cys Thr Asn
Asp Phe Gly Asn
Asp Phe Asn Gly
Asp Gly Phe Asn
Asp Gly Asn Phe
Asp Asn Cys Thr
Asp Asn Phe Gly
Asp Asn Gly Phe
Asp Asn Thr Cys
Asp Gln Cys Ser
Asp Gln Ser Cys
Asp Ser Cys Gln
Asp Ser Gln Cys
Asp Thr Cys Asn
Asp Thr Asn Cys
Glu Cys Asn Ser
Glu Cys Ser Asn
Glu Asn Cys Ser
Glu Asn Ser Cys
Glu Ser Cys Asn
Glu Ser Asn Cys
Phe Asp Gly Asn
Phe Asp Asn Gly
Phe Gly Asp Asn
Phe Gly Asn Asp
Phe Asn Asp Gly
Phe Asn Gly Asp
Gly Cys Ser Trp
Gly Cys Trp Ser
Gly Asp Phe Asn
Gly Asp Asn Phe
Gly Phe Asp Asn
Gly Phe Asn Asp
Gly Met Met Asn
Gly Met Asn Met
Gly Asn Asp Phe
Gly Asn Phe Asp
Gly Asn Met Met
Gly Ser Cys Trp
Gly Ser Trp Cys
Gly Trp Cys Ser
Gly Trp Ser Cys
Ile Cys Cys Asn
Ile Cys Asn Cys
Ile Asn Cys Cys
Leu Cys Cys Asn
Leu Cys Asn Cys
Leu Asn Cys Cys
Met Ala Cys Gln
Met Ala Gln Cys
Met Cys Ala Gln
Met Cys Gln Ala
Met Gly Met Asn
Met Gly Asn Met
Met Met Gly Asn
Met Met Asn Gly
Met Asn Gly Met
Met Asn Met Gly
Met Gln Ala Cys
Met Gln Cys Ala
Asn Cys Cys Ile
Asn Cys Cys Leu
Asn Cys Asp Thr
Asn Cys Glu Ser
Asn Cys Ile Cys
Asn Cys Leu Cys
Asn Cys Ser Glu
Asn Cys Thr Asp
Asn Asp Cys Thr
Asn Asp Phe Gly
Asn Asp Gly Phe
Asn Asp Thr Cys
Asn Glu Cys Ser
Asn Glu Ser Cys
Asn Phe Asp Gly
Asn Phe Gly Asp
Asn Gly Asp Phe
Asn Gly Phe Asp
Asn Gly Met Met
Asn Ile Cys Cys
Asn Leu Cys Cys
Asn Met Gly Met
Asn Met Met Gly
Asn Ser Cys Glu
Asn Ser Glu Cys
Asn Thr Cys Asp
Asn Thr Asp Cys
Gln Ala Cys Met
Gln Ala Met Cys
Gln Cys Ala Met
Gln Cys Cys Val
Gln Cys Asp Ser
Gln Cys Met Ala
Gln Cys Ser Asp
Gln Cys Val Cys
Gln Asp Cys Ser
Gln Asp Ser Cys
Gln Met Ala Cys
Gln Met Cys Ala
Gln Ser Cys Asp
Gln Ser Asp Cys
Gln Val Cys Cys
Arg Ala Cys Cys
Arg Cys Ala Cys
Arg Cys Cys Ala
Ser Cys Asp Gln
Ser Cys Glu Asn
Ser Cys Gly Trp
Ser Cys Asn Glu
Ser Cys Gln Asp
Ser Cys Trp Gly
Ser Asp Cys Gln
Ser Asp Gln Cys
Ser Glu Cys Asn
Ser Glu Asn Cys
Ser Gly Cys Trp
Ser Gly Trp Cys
Ser Asn Cys Glu
Ser Asn Glu Cys
Ser Gln Cys Asp
Ser Gln Asp Cys
Ser Trp Cys Gly
Ser Trp Gly Cys
Thr Cys Asp Asn
Thr Cys Asn Asp
Thr Asp Cys Asn
Thr Asp Asn Cys
Thr Asn Cys Asp
Thr Asn Asp Cys
Val Cys Cys Gln
Val Cys Gln Cys
Val Gln Cys Cys
Trp Cys Gly Ser
Trp Cys Ser Gly
Trp Gly Cys Ser
Trp Gly Ser Cys
Trp Ser Cys Gly
Trp Ser Gly Cys
4-Phenylbutyl glucosinolate
5-O-Feruloylnigrumin
4-FORMYLPHENYL 2-ACETAMIDO-3,4,6-TRI-O-ACETYL-2-DEOXY-β-D-GLUCOPYRANOSIDE
Rigosertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor D000970 - Antineoplastic Agents
4-DAMP
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists
2-Thiophenecarboxamide, 5-chloro-N-[(1R)-1-(methoxymethyl)-2-[[3-methyl-4-(3-oxo-4-morpholinyl)phenyl]amino]-2-oxoethyl]-
4-(p-dimethylaminophenyl)-2,6-diphenylpyrylium perchlorate
(5S,6R)-6-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-5-(4-fluorophenyl)-3-morpholinone
(R)-2-((1R)-3-benzyl-7-oxo-(1rH,5cH)-4-thia-2,6-diaza-bicyclo[3.2.0]hept-2-en-6-yl)-3-methyl-but-3-enoic acid 4-nitro-benzyl ester
disodium 4-[2-[(1-oxoundec-10-enyl)amino]ethyl] 2-sulphonatosuccinate
1H-BenziMidazole, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]Methyl]sulfinyl]-1-(2,2,2-trifluoroethyl)-
Ethanone, 1-(4-(4-chloro-3-methoxyphenyl)-1-piperazinyl)-2-(3-(1H-imidazol-2-yl)-1H-pyrazolo(3,4-b)pyridin-1-yl)-
4-(4-Chloro-phenyl)-1-{3-[2-(4-fluoro-phenyl)-[1,3]dithiolan-2-YL]-propyl}-piperidin-4-OL
Stilonium iodide
D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent
Piritrexim isethionate
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2153 - Dihydrofolate Reductase Inhibitor
cyano(3-phenoxyphenyl)methyl (2S)-2-[4-(difluoromethoxy)phenyl]-3-methylbutanoate
N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide
1-(4-chlorophenyl)-6-[[2-(3,4-dihydro-2H-quinolin-1-yl)-2-oxoethyl]thio]-2H-pyrazolo[3,4-d]pyrimidin-4-one
2-{4-[2-(2-Amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-D]pyrimidin-5-YL)-ethyl]-benzoylamino}-4-(2H-tetrazol-5-YL)-butyric acid
Betrixaban
B - Blood and blood forming organs > B01 - Antithrombotic agents > B01A - Antithrombotic agents > B01AF - Direct factor xa inhibitors C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C173067 - Direct Factor Xa Inhibitor C78275 - Agent Affecting Blood or Body Fluid > C263 - Anticoagulant Agent > C180619 - Direct Oral Anticoagulant D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors D006401 - Hematologic Agents > D000925 - Anticoagulants > D000991 - Antithrombins
4-Amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-hydroxybenzamide
4H-Pyrido(4',3':4,5)thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine, 7,8,9,10-tetrahydro-6-(2-chlorophenyl)-9-(cyclopropylcarbonyl)-1,4-dimethyl-, (S)-
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)pentan-1-imine
5-[(4-Fluorophenyl)methyl]-7-(4-methylphenyl)sulfonyl-[1,3]dioxolo[4,5-g]quinolin-8-one
[4-[5-Chloro-2-(3-chlorophenyl)-7-pyrazolo[1,5-a]pyrimidinyl]-1-piperazinyl]-phenylmethanone
10-(3-Carboxypropyl)-3,6-bis(dimethylamino)acridinium perchlorate
3-[[4-(1,3-benzodioxol-5-yl)-6-(trifluoromethyl)-2-pyrimidinyl]thio]-N-(2-furanylmethyl)propanamide
N-[4-[[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]phenyl]acetamide
6-[(2-ethylphenyl)sulfamoyl]-N-(2-furanylmethyl)-4-oxo-1H-quinoline-3-carboxamide
3-(4-fluorophenyl)-1-[(6-oxo-5H-[1,3]dioxolo[4,5-g]quinolin-7-yl)methyl]-1-(thiophen-2-ylmethyl)urea
3-[[2-[[6-Fluoro-2-(4-fluorophenyl)-4-quinazolinyl]thio]-1-oxoethyl]amino]benzoic acid
1-(3-Methoxyphenyl)-2-[[4-methyl-5-[[(4-phenyl-2-thiazolyl)amino]methyl]-1,2,4-triazol-3-yl]thio]ethanone
ethyl 4-{[(2E)-2-(3-methylbenzylidene)-3-oxo-3,4-dihydro-2H-1,4-benzothiazin-6-yl]carbonyl}piperazine-1-carboxylate
1-[(8R,9R,10R)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
3-fluoro-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylbenzenesulfonamide
2-[(2R,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,5S,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,5R,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)oxan-2-yl]-N-(2-pyridin-4-ylethyl)acetamide
N-[(2R,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3R,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3R,6S)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
2-[(1S,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
2-[(1R,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
2-[(1S,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
1-[(8R,9S,10S)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
1-[(8S,9R,10R)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
1-[(8S,9S,10S)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
2-[(2S,5R,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,5R,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2S,5S,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,5R,6R)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
2-[(2R,5S,6S)-5-[(4-fluorophenyl)sulfonylamino]-6-(hydroxymethyl)-2-oxanyl]-N-(2-pyridin-4-ylethyl)acetamide
N-[(2S,3R,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3S,6S)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3S,6R)-6-[2-[(3,4-dichlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
N-[(2S,3R,6R)-6-[2-[(3-fluorophenyl)sulfonylamino]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-(2-pyridinyl)acetamide
2-[(1R,3R,4aR,9aS)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
2-[(1S,3R,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
2-[(1R,3S,4aS,9aR)-6-[(4-fluorophenyl)sulfonylamino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]acetic acid methyl ester
1-[(8S,9R,10S)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
1-[(8S,9S,10R)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
1-[(8R,9R,10S)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
1-[(8R,9S,10R)-9-(4-bromophenyl)-10-(hydroxymethyl)-1,6-diazabicyclo[6.2.0]decan-6-yl]-2-(4-morpholinyl)ethanone
Lysidine monophosphate
A pyrimidine ribonucleoside 5-monophosphate that is CMP in which the 2-keto group on the cytosine ring is replaced by an epsilon-L-lysyl residue.